Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria [Immunology and Inflammation] - Patrick Strangward, Michael J. Haley, Manuel G. Albornoz, Jack Barrington, Tovah Shaw, Rebecca Dookie, Leo Zeef, Syed M. Baker, Emma Winter, Te-Chen Tzeng, Douglas T. Golenbock, Sheena M. Cruickshank, Stuart M. Allan, Alister Craig, Foo Y. Liew, David Brough, Kevin N. Couper (National Academy of Sciences, 2018)
6302214